Structural and Functional Studies of Human Serine Palmitoyltransferase Complexes
人丝氨酸棕榈酰转移酶复合物的结构和功能研究
基本信息
- 批准号:10277991
- 负责人:
- 金额:$ 36.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAmyotrophic Lateral SclerosisAnabolismApoptosisArchitectureBindingBinding SitesBiochemicalBiochemistryBiogenesisBiological ProcessBiologyBiophysicsCatalysisCellsComplementComplexCryoelectron MicroscopyDefectDiseaseEnvironmentEnzymesExhibitsFeedbackFoundationsGoalsHereditary Sensory NeuropathyHomeostasisHumanInflammationInvestigationKnowledgeLeadLinkLipid BindingLipidsMalignant NeoplasmsMediatingMembraneMembrane ProteinsMetabolismMethodsMolecularMolecular ConformationMultienzyme ComplexesMutationNerve DegenerationNeurodegenerative DisordersNeuronal DysfunctionPalmitoyl Coenzyme APathway interactionsPositioning AttributeProductionProtein BiochemistryProtein IsoformsReactionRegulationResearchResolutionRoleSerineShapesSignaling MoleculeSphingolipidsStructureSubstrate SpecificityTestingTimeWorkbasebiophysical techniquescell growthearly onsetinhibitor/antagonistinsightinterdisciplinary approachnovel therapeuticspreferenceprotein complexsensorserine palmitoyltransferasesphinganinestructural biologytumorigenesis
项目摘要
PROJECT SUMMARY
Sphingolipids not only are essential structural components of eukaryotic membranes, but also function as
signaling molecules and mediate many biological processes. Defects in sphingolipid metabolism are often
associated with cancers and neurodegenerative diseases. Despite the importance of bioactive sphingolipids,
molecular mechanisms of their biogenesis and homeostasis remain poorly understood. In humans, the first and
rate-limiting step of sphingolipid biosynthesis is catalyzed by the serine palmitoyltransferase complex, which
consists of catalytic component SPTLCs and regulatory components ssSPT and ORMDL. This key enzyme
complex also senses cellular sphingolipid levels to adjust sphingolipid production accordingly, making it a
critical feedback regulator in maintaining sphingolipid homeostasis. Human mutations in the complex lead to
hereditary sensory neuropathy and early-onset amyotrophic lateral sclerosis. However, the mechanism and
regulation of the complex are unclear. We propose to elucidate 1) the substrate recognition and catalytic
reaction of the complex, 2) the role of regulatory components, and 3) the sphingolipid-sensing and feedback
mechanism. To accomplish these aims, we will combine high-resolution structural biology, biochemistry, and
biophysics to provide structural and mechanistic insights into sphingolipid biogenesis and homeostasis
governed by the serine palmitoyltransferase complex. Our proposed studies will greatly advance our
understanding of sphingolipid biology by uncovering the molecular basis of an essential step in sphingolipid
biogenesis and a mechanism of sphingolipid homeostasis.
项目摘要
鞘脂不仅是真核生物膜的重要结构成分,
信号分子和介导许多生物过程。鞘脂代谢缺陷通常是
与癌症和神经退行性疾病有关。尽管生物活性鞘脂很重要,
它们的生物发生和体内平衡的分子机制仍然知之甚少。在人类中,第一个和
鞘脂生物合成的限速步骤由丝氨酸棕榈酰转移酶复合物催化,
由催化组分SPTLC和调节组分ssSPT和ORMDL组成。这种关键酶
复合物还能感知细胞鞘脂水平,从而相应地调节鞘脂的产生,使其成为一种
在维持鞘脂体内平衡的关键反馈调节剂。人类基因突变导致
遗传性感觉神经病和早发性肌萎缩侧索硬化症。然而,该机制和
复杂的规则尚不清楚。我们建议阐明1)底物识别和催化
复合物的反应,2)调节成分的作用,以及3)鞘脂传感和反馈
机制为了实现这些目标,我们将联合收割机结合高分辨率的结构生物学,生物化学,
生物物理学提供结构和机制的见解鞘脂生物合成和稳态
由丝氨酸棕榈酰转移酶复合物控制。我们提出的研究将大大促进我们的
通过揭示鞘脂中一个重要步骤的分子基础来了解鞘脂生物学
生物发生和鞘脂体内平衡的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chia-Hsueh Lee其他文献
Chia-Hsueh Lee的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chia-Hsueh Lee', 18)}}的其他基金
Structural and Functional Studies of Human Serine Palmitoyltransferase Complexes
人丝氨酸棕榈酰转移酶复合物的结构和功能研究
- 批准号:
10609516 - 财政年份:2021
- 资助金额:
$ 36.8万 - 项目类别:
Structural and Functional Studies of Human Serine Palmitoyltransferase Complexes
人丝氨酸棕榈酰转移酶复合物的结构和功能研究
- 批准号:
10451590 - 财政年份:2021
- 资助金额:
$ 36.8万 - 项目类别:
相似海外基金
Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
- 批准号:
MR/Y014901/1 - 财政年份:2024
- 资助金额:
$ 36.8万 - 项目类别:
Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
- 批准号:
MR/Y014286/1 - 财政年份:2024
- 资助金额:
$ 36.8万 - 项目类别:
Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
- 批准号:
MR/Y503502/1 - 财政年份:2024
- 资助金额:
$ 36.8万 - 项目类别:
Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
- 批准号:
2317745 - 财政年份:2023
- 资助金额:
$ 36.8万 - 项目类别:
Standard Grant
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
- 批准号:
10759808 - 财政年份:2023
- 资助金额:
$ 36.8万 - 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
- 批准号:
10606865 - 财政年份:2023
- 资助金额:
$ 36.8万 - 项目类别:
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
- 批准号:
10696512 - 财政年份:2023
- 资助金额:
$ 36.8万 - 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
- 批准号:
10848139 - 财政年份:2023
- 资助金额:
$ 36.8万 - 项目类别:
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
- 批准号:
MR/Y001095/1 - 财政年份:2023
- 资助金额:
$ 36.8万 - 项目类别:
Fellowship
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
- 批准号:
488892 - 财政年份:2023
- 资助金额:
$ 36.8万 - 项目类别:
Operating Grants